Back
Speaker illustration

undefined undefined undefined

Presentations Articles

Right-sided cardiac echocardiographic parameters show no major change during 3-months mavacamten treatment in obstructive hypertrophic cardiomyopathy

Event: EACVI 2025

Topic: Myocardial Disease

Session: What is new in hypertrophic cardiomyopathy

Access
Like
Thumbnail

Optimal timing of of cardiac implantable electronic device reoperation

Event: EHRA 2024

Topic: Device Complications and Lead Extraction

Session: Devices: complications

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources